APO-Mometasone nasal spray recalled due to potential bacteria contamination
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 19/02/2024 (927 days ago), so information in it may no longer be current.
Drug company Apotex is recalling two lots of a prescription nasal spray due to possible bacterial contamination.
APO-Mometasone nasal spray is prescribed for allergy symptoms in children, for sinusitis in patients aged 12 and older, and for nasal polyps in adults.
Health Canada says the recalled lots may be contaminated with Burkholderia cepacia complex bacteria, which can pose serious health risks to people with chronic lung diseases or weakened immune systems, those who are pregnant, as well as seniors and children.
The affected APO-Mometasone sprays are from lot numbers TX5343 and TZ2586 and have expiry dates of September and October 2025.
Health Canada says anyone who has the recalled sprays should return them to a local pharmacy for proper disposal.
Anyone concerned because they or their children have used the product should consult a health-care provider.
Health Canada says Burkholderia cepacia complex bacteria pose a low risk to most healthy people.
Symptoms of an infection include fever and facial pain or pressure.
This report by The Canadian Press was first published Feb. 19, 2024.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
